A preliminary agenda for the 15th Annual State-of-the-Art Echo Course is now available at: http://www.nyechocourse.com/the-conference/agenda.html.
The three-day conference will feature the latest recommendations from the American Society of Echocardiography (ASE) for echocardiographic evaluation of cardiac structure and function, as well as the most recent technological advances in the field. Topics at this year's meeting will include:
There are few noninvasive and nonradiographic imaging tests that can yield as much information about the heart as an echocardiogram. A noninvasive tool with a high safety profile that is well accepted by patients, echocardiography is an invaluable tool for assessing disease effects and treatment outcomes on cardiac structure and function. Newer echocardiographic tools continue to advance our understanding of myocardial mechanics and disease detection.
This year's conference will feature nationally recognized experts who will present the most up-to-date research in the field as well as hands-on demonstrations of basic and advanced Doppler echocardiography.
Rebecca T. Hahn, MD will serve as Course Director. She is the Director of Interventional Echocardiography at NewYork-Presbyterian Hospital/Columbia University Medical Center and Associate Professor of Clinical Medicine at the Columbia College of Physicians and Surgeons. Dr. Hahn previously directed the echocardiography lab at North Shore University Hospital and was the Director of Clinical Echocardiography at Cornell University.
April 3-5, 2013
The Roosevelt Hotel
45 East 45th Street
New York, NY
HOW TO REGISTER:
Media may apply for registration by emailing firstname.lastname@example.org.
The Cardiovascular Research Foundation (CRF) is an independent, academically focused nonprofit organization dedicated to improving the survival and quality of life for people with cardiovascular disease through research and education. Since its inception in 1991, CRF has played a major role in realizing dramatic improvements in the lives of countless numbers of patients by establishing the safe use of new technologies and therapies in interventional cardiovascular medicine.
AAAS and EurekAlert! are not responsible for the accuracy of news releases posted to EurekAlert! by contributing institutions or for the use of any information through the EurekAlert! system.